Thursday, November 26, 2020

Washington, DC--An independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273 reviewed trial...

Atlanta, GA--CDC, public health and regulatory officials in several states, and the U.S. Food and Drug Administration are investigating several multistate outbreaks of E....

Washington, DC--Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate...

Washington, DC--Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to...

Washington, DC--A study published today in JAMA Network Open shows that children from poorer neighborhoods perform less well on a range of cognitive functions, such as...

Atlanta, GA--Today the Centers for Disease Control and Prevention (CDC) issued a Framework for Conditional Sailing Order that introduces a phased approach for the...

Washington, DC--U.S. health, housing, and environmental agencies warn that some 3.6 million U.S. families risk permanent harm to their children because their homes are...

Atlanta, GA--10 people infected with the outbreak strain of Listeria have been reported from Florida, Massachusetts, and New York. All 10 ill people were hospitalized. One death...

Washington, DC--Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and...

Washington, DC--Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved...